OFOrna Fennelly

Orna Fennelly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Orna Fennelly has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AI in Neurological Health Care: Qualitative Study of Patient and Public Perceptions

    by Tina Bedenik, Orna Fennelly, Kathleen Bennett

    Background: Globally, health systems face increasing challenges due to improved life expectancy, rising levels of disease, greater expectations for health care, and growing expenditure. AI-based technologies are increasingly used to support clinical decision-making and contribute to effective delivery of care. AI has significant potential in terms of diagnostics and treatment for preventive and personalized medicine, including progressive, nonprogressive, or neurodivergent conditions affecting the brain, spinal cord, and nerves. Although AI has been extensively applied to several areas of health, its application to neurological conditions remains limited. Objective: This qualitative study explores the perspectives of patients and the public impacted by neurological conditions on the use of AI in health care in Ireland. It focused on the benefits and concerns regarding AI implementation to inform effective and safe use of AI in clinical decision-making. Methods: We conducted a qualitative cross-sectional study using focus groups of patients and the public (family members). A combination of purposive and snowball sampling was used in participant recruitment. The sample consisted of 15 participants involved in 2 focus groups, most commonly with conditions including early-onset Parkinson disease, epilepsy, and multiple sclerosis. Qualitative data were transcribed, and thematic data analysis was undertaken using NVivo (version 12; Lumivero) software. Results: The main benefits of AI in clinical decision-making included improved diagnostics and treatment for neurological health care, increased patient involvement in care and decision-making, and resource efficiency. Participants believed that AI-powered systems could assist with information collation and decision-making, and AI could be an aid in simple repetitive tasks, allowing clinicians more time for clinical work. The concerns included preparedness of the national health data ecosystem, harm resulting from AI application, and overreliance on AI resulting in deskilling. Participants were generally supportive of AI in clinical decision-making; however, their support was conditional on a stringent regulatory framework and human supervision over AI use. Conclusions: Neurological conditions have a significant impact on the lives of patients and their families, with large resource implications for the health care system. AI has the potential to contribute to significant benefits, such as improved diagnostics, resource efficiency, novel insights, and improved provision of health care. However, the health care system needs to focus on the readiness and availability of health data. This study highlights the importance of preparing health systems for the expansion of AI systems, including supporting clinicians and patients in the appropriate and safe implementation of AI in health care.

  • Open Access

    AI in Neurological Health Care: Qualitative Study of Patient and Public Perceptions (Preprint)

    by Tina Bedenik, Orna Fennelly, Kathleen Bennett

    BACKGROUND Globally, health systems face increasing challenges due to improved life expectancy, rising levels of disease, greater expectations for health care, and growing expenditure. AI-based technologies are increasingly used to support clinical decision-making and contribute to effective delivery of care. AI has significant potential in terms of diagnostics and treatment for preventive and personalized medicine, including progressive, nonprogressive, or neurodivergent conditions affecting the brain, spinal cord, and nerves. Although AI has been extensively applied to several areas of health, its application to neurological conditions remains limited. OBJECTIVE This qualitative study explores the perspectives of patients and the public impacted by neurological conditions on the use of AI in health care in Ireland. It focused on the benefits and concerns regarding AI implementation to inform effective and safe use of AI in clinical decision-making. METHODS We conducted a qualitative cross-sectional study using focus groups of patients and the public (family members). A combination of purposive and snowball sampling was used in participant recruitment. The sample consisted of 15 participants involved in 2 focus groups, most commonly with conditions including early-onset Parkinson disease, epilepsy, and multiple sclerosis. Qualitative data were transcribed, and thematic data analysis was undertaken using NVivo (version 12; Lumivero) software. RESULTS The main benefits of AI in clinical decision-making included improved diagnostics and treatment for neurological health care, increased patient involvement in care and decision-making, and resource efficiency. Participants believed that AI-powered systems could assist with information collation and decision-making, and AI could be an aid in simple repetitive tasks, allowing clinicians more time for clinical work. The concerns included preparedness of the national health data ecosystem, harm resulting from AI application, and overreliance on AI resulting in deskilling. Participants were generally supportive of AI in clinical decision-making; however, their support was conditional on a stringent regulatory framework and human supervision over AI use. CONCLUSIONS Neurological conditions have a significant impact on the lives of patients and their families, with large resource implications for the health care system. AI has the potential to contribute to significant benefits, such as improved diagnostics, resource efficiency, novel insights, and improved provision of health care. However, the health care system needs to focus on the readiness and availability of health data. This study highlights the importance of preparing health systems for the expansion of AI systems, including supporting clinicians and patients in the appropriate and safe implementation of AI in health care.

  • Top Cited Papers
    Open Access

    Use of standardized terminologies in clinical practice: A scoping review

    by Orna Fennelly, Loretto Grogan, Angela Reed, Nicholas R. Hardiker


  • Top Cited Papers
    Open Access

    Successfully implementing a national electronic health record: a rapid umbrella review

    by Orna Fennelly, Caitriona Cunningham, Loretto Grogan, Heather Cronin, Conor O’sHea, Miriam Roche, Fiona Lawlor, Neil O’hAre


  • Response to letter to the editor regarding “advanced musculoskeletal physiotherapy practice: Informing education curricula"

    by Orna Fennelly, François Desmeules, Cliona O'SUllivan, Nicola R Heneghan, Caitriona Cunningham

  • Open Access

    Advanced musculoskeletal physiotherapy practice: Informing education curricula

    by Orna Fennelly, François Desmeules, Cliona O'SUllivan, Nicola R Heneghan, Caitriona Cunningham


  • Advanced musculoskeletal physiotherapy practice: The patient journey and experience

    by Orna Fennelly, Catherine Blake, Oliver FitzGerald, Aoife Caffrey, Laura Fletcher, Keith Smart, Siobhan Corcoran, Éidín Ní Shé, Sarah Casserley-Feeney, François Desmeules, et al.


  • Open Access

    Advanced musculoskeletal physiotherapy practice in Ireland: A National Survey

    by Orna Fennelly, Catherine Blake, Oliver FitzGerald, Roisin Breen, Cliona O'SUllivan, Marie O'MIr, François Desmeules, Caitriona Cunningham

    Background: Since 2011, advanced practice physiotherapists (APPs) have triaged the care of patients awaiting orthopaedic and rheumatology consultant/specialist doctor appointments in Ireland. APP services have evolved across the major hospitals (n = 16) and, after 5 years, profiling and evaluation of APP services was warranted. The present study profiled the national musculoskeletal APP services, focusing on service, clinician and patient outcome factors.Methods: An online survey of physiotherapists in the allocated APP posts (n = 25) explored: service organization; clinician profile and experience of the advanced role; and patient wait times and outcome measures. Descriptive statistics were used to analyse hospital‐ and clinician‐specific data, and a content analysis was performed to explore APP experiences.Results: A 68% (n = 17) response from 13 sites was achieved, whereby 20 whole‐time APP posts existed in services led by 91 consultant doctors. Co‐location of APP and consultant clinics at 11 sites facilitated joint medical–APP processes, with between‐site differences in autonomy to screen referral letters, and arrange investigations, injections and surgery. Although 83% had postgraduate qualifications, APPs also availed themselves of informal role‐specific training. Positive APP experiences related to learning opportunities and clinical support networks but experiences were consultant dependent, with further service developments and formal training required to manage workloads. APPs reported reduced wait times and most commonly chose to capture function/disability in future evaluations.Conclusions: Variances existed in the organizational design and operating of APP services. Although highly experienced and qualified, APPs welcomed additional formal training and support, due to the complex, more medical nature of APP roles. Further formal evaluation, capturing patient outcomes, is proposed.


  • Open Access

    Advanced practice physiotherapy-led triage in Irish orthopaedic and rheumatology services: national data audit

    by Orna Fennelly, Catherine Blake, Oliver FitzGerald, Roisin Breen, Jennifer Ashton, Aisling Brennan, Aoife Caffrey, François Desmeules, Caitriona Cunningham

    Many people with musculoskeletal (MSK) disorders wait several months or years for Consultant Doctor appointments, despite often not requiring medical or surgical interventions. To allow earlier patient access to orthopaedic and rheumatology services in Ireland, Advanced Practice Physiotherapists (APPs) were introduced at 16 major acute hospitals. This study performed the first national evaluation of APP triage services. Throughout 2014, APPs (n = 22) entered clinical data on a national database. Analysis of these data using descriptive statistics determined patient wait times, Consultant Doctor involvement in clinical decisions, and patient clinical outcomes. Chi square tests were used to compare patient clinical outcomes across orthopaedic and rheumatology clinics. A pilot study at one site identified re-referral rates to orthopaedic/rheumatology services of patients managed by the APPs. In one year, 13,981 new patients accessed specialist orthopaedic and rheumatology consultations via the APP. Median wait time for an appointment was 5.6 months. Patients most commonly presented with knee (23%), lower back (22%) and shoulder (15%) disorders. APPs made autonomous clinical decisions regarding patient management at 77% of appointments, and managed patient care pathways without onward referral to Consultant Doctors in more than 80% of cases. Other onward clinical pathways recommended by APPs were: physiotherapy referrals (42%); clinical investigations (29%); injections administered (4%); and surgical listing (2%). Of those managed by the APP, the pilot study identified that only 6.5% of patients were re-referred within one year. This national evaluation of APP services demonstrated that the majority of patients assessed by an APP did not require onward referral for a Consultant Doctor appointment. Therefore, patients gained earlier access to orthopaedic and rheumatology consultations in secondary care, with most patients conservatively managed.